On May 28th, French Health Minister François Braun announced plans to allow pharmacists to prescribe electronic cigarettes as a nicotine replacement therapy. However, Braun clarified that these prescriptions will not include "puffs" (the French term for disposable e-cigarettes) as they are "of no help in quitting smoking.
Braun reiterated his plan to ban disposable electronic cigarettes, stating on a French news program that "Disposable electronic cigarettes do not help people quit smoking.
French lawmakers are hoping to implement a ban on "disposable e-cigarettes" in the fall of 2023. However, as the Minister of Health, Olivier Véran, has also stated that he is considering "allowing pharmacists to prescribe e-cigarette products as a nicotine replacement therapy.
He stated that the prescription will not include "these colorful disposable products" which "encourage young people to smoke". The prescription will only include "nicotine replacement products and e-cigarettes" which "can gradually reduce nicotine consumption and help smokers quit".
When asked about taxation issues, Braun replied that this matter is "on the table as part of the government's next anti-smoking campaign," which is planned to be implemented between 2023 and 2028.
He also said:
All tobacco products, such as heated tobacco and chewing tobacco, are taxed in the same way as cigarettes.
Previously, Braun stated that the French government may ban disposable e-cigarettes before the end of this year, as it becomes part of the Ministry of Health's "New Anti-Smoking Plan" that will be implemented over the next five years.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
